L&C BIO Co.,LTD (KOSDAQ:290650)

L&C BIO Co.,LTD Revenue

L&C BIO Co.,LTD had revenue of 30.29B KRW in the quarter ending March 31, 2026, with 71.44% growth. This brings the company's revenue in the last twelve months to 98.10B, up 34.07% year-over-year. In the year 2025, L&C BIO Co.,LTD had annual revenue of 85.48B with 18.66% growth.

• Revenue (ttm): 98.10B
• Revenue Growth: +34.07%
• P/S Ratio: 20.51
• Revenue / Employee: 695.75M
• Employees: 141
• Market Cap: 2.01T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	85.48B	13.44B	18.66%
Dec 31, 2024	72.03B	6.11B	9.26%
Dec 31, 2023	65.93B	13.35B	25.40%
Dec 31, 2022	52.57B	6.90B	15.10%
Dec 31, 2021	45.68B	12.70B	38.53%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 10, 2026

Data Sources Report a data error